As of June 30, 2024 and December 31, 2023, the company had cash, cash equivalents and marketable securities totaling $245.0 million and $303.5 million, respectively.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLVX:
- HilleVax Announces Reduction in Force
- HilleVax announces 40% workforce reduction to reduce operating expenses
- HilleVax, Inc. Clears $26.2M Debt and Ends Loan Agreement
- HilleVax downgraded to Market Perform from Outperform at Leerink
- Tempus AI initiated, Helios downgraded: Wall Street’s top analyst calls